Journal Scans
Efficacy of Chemotherapy With Carboplatin and Paclitaxel for Unresectable Thymic Carcinoma
Carboplatin Plus Paclitaxel for Unresectable Thymic Carcinoma
S Igawa, H Murakami, T Takahashi, Y Nakamura, A Tsuya, T Naito, K Kaira, A Ono, T Shukuya, A Tamiya, M Endo, N Yamamoto
20100101
2010 Feb 1
Lung Cancer
Efficacy of Chemotherapy With Carboplatin and Paclitaxel for Unresectable Thymic Carcinoma
Lung Cancer. 2010 Feb 1;67(2):194-197, S Igawa, H Murakami, T Takahashi, Y Nakamura, A Tsuya, T Naito, K Kaira, A Ono, T Shukuya, A Tamiya, M Endo, N Yamamoto
TAKE-HOME MESSAGE
Abstract
Abstract
Background: Thymic carcinoma is a very rarely encountered neoplasm and no optimal chemotherapeutic regimen has been established yet. Methods: The records of previously untreated thymic carcinoma patients with unresectable disease who had been treated with paclitaxel and carboplatin as first-line chemotherapy between 2003 and 2008 were reviewed, retrospectively. Paclitaxel was administered at the dose of 200mg/m2 and carboplatin at an AUC of 6 on day 1, with the treatment cycle repeated every 3...
